Works matching IS 09255710 AND DT 2020 AND VI 112 AND IP 4


Results: 21
    1

    Retrospective multi-center study of Adolescent and Young Adult (AYA) Multiple Myeloma in Kansai Myeloma Forum registry.

    Published in:
    International Journal of Hematology, 2020, v. 112, n. 4, p. 435, doi. 10.1007/s12185-020-02996-6
    By:
    • Nakaya, Aya;
    • Kohara, Takae;
    • Shibayama, Hirohiko;
    • Onda, Yoshiyuki;
    • Kanda, Junya;
    • Kaneko, Hitomi;
    • Imada, Kazunori;
    • Kida, Toru;
    • Kosugi, Satoru;
    • Ishikawa, Jun;
    • Yamamura, Ryosuke;
    • Shimazu, Yutaka;
    • Tanaka, Hirokazu;
    • Fuchida, Shin-ichi;
    • Shimura, Yuji;
    • Kiyota, Miki;
    • Wada, Katsuya;
    • Ito, Tomoki;
    • Uoshima, Nobuhiko;
    • Yagi, Hideo
    Publication type:
    Article
    2
    3
    4
    5

    Results from multinational phase 3 studies of ravulizumab (ALXN1210) versus eculizumab in adults with paroxysmal nocturnal hemoglobinuria: subgroup analysis of Japanese patients.

    Published in:
    International Journal of Hematology, 2020, v. 112, n. 4, p. 466, doi. 10.1007/s12185-020-02934-6
    By:
    • Ishiyama, Ken;
    • Nakao, Shinji;
    • Usuki, Kensuke;
    • Yonemura, Yuji;
    • Ikezoe, Takayuki;
    • Uchiyama, Michihiro;
    • Mori, Yasuo;
    • Fukuda, Tetsuya;
    • Okada, Masaya;
    • Fujiwara, Shin-ichiro;
    • Noji, Hideyoshi;
    • Rottinghaus, Scott;
    • Aguzzi, Rasha;
    • Yokosawa, Jun;
    • Nishimura, Jun-Ichi;
    • Kanakura, Yuzuru;
    • Okamoto, Shinichiro
    Publication type:
    Article
    6
    7
    8

    Differences among hemoglobin thresholds for red blood cell transfusions in patients with hematological diseases in teaching hospitals: a real world data in Japan.

    Published in:
    International Journal of Hematology, 2020, v. 112, n. 4, p. 535, doi. 10.1007/s12185-020-02937-3
    By:
    • Yokohama, Akihiko;
    • Okuyama, Yoshiki;
    • Ueda, Yasunori;
    • Itoh, Masumi;
    • Fujiwara, Shin-ichiro;
    • Hasegawa, Yuichi;
    • Nagai, Kazuhiro;
    • Arakawa, Kimika;
    • Miyazaki, Koji;
    • Makita, Masanori;
    • Watanabe, Mai;
    • Ikeda, Kazuhiko;
    • Tanaka, Asashi;
    • Fujino, Keizo;
    • Matsumoto, Mayumi;
    • Makino, Shigeyoshi;
    • Kino, Shuichi;
    • Takeshita, Akihiro;
    • Muroi, Kazuo
    Publication type:
    Article
    9
    10
    11
    12

    Myeloablative intravenous busulfan-containing regimens for allo-HSCT in AML or MDS patients over 54 years old: combined results of three phase II studies.

    Published in:
    International Journal of Hematology, 2020, v. 112, n. 4, p. 510, doi. 10.1007/s12185-020-02941-7
    By:
    • Uchida, Naoyuki;
    • Matsumoto, Kana;
    • Sakura, Toru;
    • Hidaka, Michihiro;
    • Miyamoto, Toshihiro;
    • Eto, Tetsuya;
    • Maeda, Yoshinobu;
    • Murayama, Tohru;
    • Fujishima, Naohito;
    • Yoshimoto, Goichi;
    • Morita, Kunihiko;
    • Kishimoto, Junji;
    • Teshima, Takanori;
    • Taniguchi, Shuichi;
    • Yamashita, Takuya;
    • Mori, Shin-ichiro;
    • Akashi, Koichi;
    • Harada, Mine
    Publication type:
    Article
    13
    14
    15
    16
    17
    18

    Programmed death 1 ligand (PD-L1) in solid cancers after allogeneic hematopoietic stem cell transplantation: a retrospective analysis by the Nagasaki Transplant Group.

    Published in:
    International Journal of Hematology, 2020, v. 112, n. 4, p. 524, doi. 10.1007/s12185-020-02926-6
    By:
    • Kasai, Sachie;
    • Itonaga, Hidehiro;
    • Niino, Daisuke;
    • Miyoshi, Hiroaki;
    • Kato, Takeharu;
    • Imanishi, Daisuke;
    • Fujioka, Machiko;
    • Furumoto, Takafumi;
    • Sato, Shinya;
    • Sawayama, Yasushi;
    • Taguchi, Jun;
    • Imaizumi, Yoshitaka;
    • Hata, Tomoko;
    • Yoshida, Shinichiro;
    • Moriuchi, Yukiyoshi;
    • Ohshima, Koichi;
    • Miyazaki, Yasushi
    Publication type:
    Article
    19
    20
    21